In general, the importance of the RUNX1/PDIA5/CCAR1 signaling axis in the progression of GBM was identified in this study, which is expected to be a potential target and a basic concept for the development of a new strategy to inhibit the malignant progression of GBM. This evidence concerns the gene PDIA5 and glioblastoma.